Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Health

2026 opens with the biggest January for corporate investment in years

With more than $37bn invested across 444 deals, January 2026 saw corporates deploy more venture money than in almost any month in the past two years.


Feb 9, 2026

Servier's new €200m startup fund looks to plug Europe's biotech funding gap

Europe has strong life sciences research and lower costs, but still has a funding gap for early-stage companies, says Alexis Vandier, who is heading the French pharma company's new fund.

Feb 6, 2026

Cascarano joins Johnson & Johnson MedTech as head of global ventures

Ceili Cascarano will lead global investments and acquisitions.

Feb 5, 2026

German media company Bertelsmann establishes health tech startup fund

The new fund – Bertelsmann Healthcare Investments – will provide capital and expertise to help startups develop and scale their business models.

Jan 30, 2026

GE gets back in the CVC game with healthcare venture unit

General Electric is hiring for a corporate venture arm that will invest on behalf of GE Healthcare, returning to CVC after a five-year gap.

Jan 28, 2026

Baran leaves Pfizer’s startup investment team

He will take the helm of a healthcare hedge fund’s private investments strategy.

Jan 27, 2026

Denmark's Novo Holdings hires Sheikh as quantum investor

Amer Sheikh, who was previously at HSBC Ventures, will co-lead Novo Holdings' quantum investments.

Jan 23, 2026

New year, new you? Here are 10 startups that can help you…

Whether it's giving up vices, improving your health or finally launching that big personal project, here are 10 startups with tech that can help.

Jan 13, 2026

Biotech company Servier launches $234m venture fund

The French biotech company's €200m Servier Ventures unit will initially target oncology and neurology startups, focusing on Europe.

Jan 12, 2026

University of Pennsylvania launches $50m fund with pharma group BioNTech

The US Ivy League institution has had some recent successful exits of life science spinouts.

Jan 12, 2026

Dowlin leaves investment arm of US federal benefits provider GEHA

Kiel Dowlin led the ventures arm for two-and-a-half years.

Jan 9, 2026

Healthcare investors hope for more early-stage and exit activity going into 2026

After a rough few years for healthcare investment, the exits market is opening up and healthcare admin, AI and data are catching investor’s eyes.

Jan 8, 2026
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here